Guidelines for the treatment of tympanostomy tube otorrhea

Journal of Otolaryngology

Volumn 34, Issue SUPPL. 2, 2006, Pages

  Daniel, Sam J ^a   Kozak, Frederick K ^b   Fabian, M Clifford ^c   Hekkenberg, Robert ^d   Hruby, Lorna E ^c   Harjee, Karim S ^c   Rana, Ranjit ^c   Lubell, Richard F ^e   Hawke, Michael ^f  

^a MONTREAL CHILDREN S HOSPITAL   (Canada)

^b BC CHILDREN S HOSPITAL   (Canada)

^c Royal Victoria Hospital ^*

^d Royal Victoria Hospital Barrie   (Canada)

^e UNIVERSITY OF WESTERN ONTARIO   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

Guidelines; Otorrhea; Ototoxicity; Topical therapy; Tympanostomy tubes

Indexed keywords

AMINOGLYCOSIDE DERIVATIVE; ANTIBIOTIC AGENT; BETAMETHASONE; CIPRODEX; CIPROFLOXACIN; CLIOQUINOL PLUS FLUMETASONE PIVALATE; CORTISPORIN; DEXAMETHASONE; EAR DROPS; FRAMYCETIN; GARASONE; GENTAMICIN; GRAMICIDIN; NEOMYCIN; POLYSPORIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SOFRACORT; STEROID; ANTIINFECTIVE AGENT;

ACUTE OTITIS MEDIA; ANTIBIOTIC THERAPY; BIOFILM; CANADA; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; DRUG SAFETY; HUMAN; INNER EAR DISEASE; MEDICAL PRACTICE; MEDICAL SOCIETY; MEDICAL SPECIALIST; OTORRHEA; OTOTOXICITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT FAILURE; TYMPANOSTOMY TUBE; VESTIBULAR DISORDER; CONSENSUS DEVELOPMENT; MIDDLE EAR VENTILATION; OTITIS MEDIA; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANTI-BACTERIAL AGENTS; HUMANS; MIDDLE EAR VENTILATION; OTITIS MEDIA;

EID: 25444494780     PISSN: 03816605     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (25)

1. Ah-Tye C, Paradise JL, Colborn DK. Otorrhea in young children after tympanostomy-tube placement for persistent middle-ear effusion: prevalence, incidence, and duration. Pediatrics 2001;107:1251-8.
2. Goldstein NA, Mandel EM, Kurs-Lasky M, et al. Water precautions and tympanostomy tubes: a randomized, controlled trial. Laryngoscope 2005;115:324-30.
3. Lindstrom DR, Reuben B, Jacobson K, et al. Long-term results of Armstrong beveled grommet tympanostomy tubes in children. Laryngoscope 2004;114:490-4.
4. Rosenfeld RM. Surgical prevention of otitis media. Vaccine 2000;19 Suppl 1:S134-9.
5. Myer CM III. Post-tympanostomy tube otorrhea. Ear Nose Throat J 2001;80(6 Suppl):4-7.
6. Meyerhoff WL, Marple BG, Roland PS. Tympanic membrane, middle ear, and mastoid. In: Roland PS, Marple BF, Meyerhoff WL, editors. Hearing loss. New York: Thieme Medical Publishers; 1997. p. 155-93.
7. Dohar JE, Garner ET, Nielsen RW, et al. Topical ofloxacin treatment of otorrhea in children with tympanostomy tubes. Arch Otolaryngol Head Neck Surg 1999;125:537-45.
8. Hannley MT, Denneny JC III, Holzer SS. Use of ototopical antibiotics in treating 3 common ear diseases. Otolaryngol Head Neck Surg 2000;122:934-40.
9. Goldblatt EL. Efficacy of ofloxacin and other otic preparations for acute otitis media in patients with tympanostomy tubes. Pediatr Infect Dis J 2001;20:116-9.
10. Post JC. Direct evidence of bacterial biofilms in otitis media. Laryngoscope 2001;111:2083-94.
11. Oberman JP, Derkay CS. Posttympanostomy tube otorrhea. Am J Otolaryngol 2004;25:110-7.
12. Roland PS. Characteristics of systemic and topical agents implicated in toxicity of the middle and inner ear. Ear Nose Throat J 2003;82 Suppl 1:3-8.
13. Hawkins JE, Johnson LG. Histopathology of cochlear and vestibular ototoxicity in laboratory animals, In: ,editor Aminoglycoside ototoxicity: Little, Brown and Co; 1981. p. 175-97.
14. Matz G, Rybak L, Roland PS, et al. Ototoxicity of ototopical antibiotic drops in humans. Otolaryngol Head Neck Surg 2004;130(3 Suppl):S79-82.
15. Zipfel TE, Wood WE, Street DF, et al. The effect of topical ciprofloxacin on postoperative otorrhea after tympanostomy tube insertion. Am J Otol 1999;20:416-20.
16. Brownlee RE, Hulka GF, Prazma J, et al. Ciprofloxacin: use as a topical otic preparation. Arch Otolaryngol Head Neck Surg 1992;118:392-6.
17. Nomura M, Yamada M, Yamamura H, et al. Ophthalmotoxicity and ototoxicity of the new quinolone antibacterial agent levofloxacin in Long Evans rats. Drug Res 1992;43:398-403.
18. Russell PT, Church CA, Jinn TH, et al. Effects of common topical otic preparations on the morphology of isolated cochlear outer hair cells. Acta Otolaryngol (Stockh) 2001;121:135-9.
19. Lancaster JL, Makura ZG, Porter G, et al. Topical aminoglycosides in the management of active mucosal chronic suppurative otitis media. J Laryngol Otol 1999;113:10-2.
20. Chen DJM, Wiliamson PA, Hutchin T, et al. Topical gentamicin-induced hearing loss: a mitochondrial ribosomal RNA study of genetic susceptibility. Am J Otol 1996;17:850-2.
21. Marais EJ, Rutka JA. Ototoxicity and topical eardrops. Clin Otolaryngol 1998;23(4):360-7.
22. Bath AP, Walsh RM, Bance ML, et al. Ototoxicity of topical gentamicin preparations. Laryngoscope 1999;109:1088-93.
23. Roland PS, Anon JB, Moe RD, et al. Topical ciprofloxacin/dexamethasone is superior to ciprofloxacin alone in pediatric patients with acute otitis media and otorrhea through tympanostomy tubes. Laryngoscope 2003;113:2116-22.
24. Roland PS, Stewart MG, Hannley M, et al. Consensus panel on role of potentially ototoxic antibiotics for topical middle ear use: introduction, methodology, and recommendations. Otolaryngol Head Neck Surg 2004;130(3 Suppl):S51-6.
25. Hawke M. Ototopical guidelines for the safe use of antibiotic containing eardrops. Ontario Medical Association Newsletter Sept 2004.